Brompton Global Healthcare Income & Growth ETFTSX:HIG
- LAST PRICE8.57
- TODAY'S CHANGE (%)-0.04 (-0.46%)
- Bid / Lots8.20/ 1
- Ask / Lots9.60/ 5
- Open / Previous Close8.57 / 8.61
- Day Range
- 52 Week Range
- Volume800
- Overall Morningstar RatingNot Ratedout of funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HIG |
|---|---|---|
| 03:52 ET | 300 | 8.57 |
| 03:59 ET | 500 | 8.57 |
| US Equity | 83.9% |
|---|---|
| Int'l Equity | 16.0% |
| Cash | 0.2% |
| CDN Equity | 0 |
| Fixed Income | 0 |
| Other | 0 |
| Healthcare | 99.9% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 84.0% |
|---|---|
| Europe | 3.0% |
| Latin America | 0 |
| Africa | 0 |
| Canada | 0 |
| Asia/Oceania | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Merck & Co Inc | Long | 5.2% | -0.47% | $2.9M |
Cencora Inc | Long | 5.1% | -0.48% | $2.9M |
Eli Lilly and Co | Long | 4.7% | -0.48% | $2.6M |
HCA Healthcare Inc | Long | 4.7% | -0.48% | $2.6M |
Stryker Corp | Long | 4.6% | -0.47% | $2.6M |
McKesson Corp | Long | 4.6% | -0.48% | $2.5M |
West Pharmaceutical Services Inc | Long | 4.6% | -0.48% | $2.5M |
Vertex Pharmaceuticals Inc | Long | 4.6% | -0.47% | $2.5M |
AstraZeneca PLC ADR | Long | 4.5% | -0.47% | $2.5M |
AbbVie Inc | Long | 4.5% | -0.48% | $2.5M |
Reports
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
|---|---|
Category | Sector Equity |
Sponsor | Brompton Funds Limited |
Inception | September 24, 2015 |
The investment objective of the Fund is to provide holders of Units (“Unitholdersâ€) of the Brompton ETF with: (a) stable monthly cash distributions; (b) the opportunity for capital appreciation; and (c) lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of Healthcare Companies (as defined herein) directly. The Fund seeks to hedge substantially all of its direct exposure to foreign currencies back to the Canadian dollar. However, any exposure that the Fund’s assets allocable to the USD Units have to foreign currencies will not be hedged.
| Total Net Assets | $54.7M |
|---|---|
| Shares Out. | 6.2M |
| Net Asset Value (NAV) | $8.56 |
| Prem/Discount to NAV | 0.12% |
| P/E Ratio | 32.1 |
| Dividend Yield | 7.70% |
| Dividend per Share | 0.66 CAD |
| Ex-Dividend Date | 04/29/2024 |
| Dividend Payment Date | 05/14/2024 |
| Beta | --- |
| Morningstar Investment Style | Sector Equity |
| Equity Style | Large Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.75% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.96% |